Moderna shares sink after leaked cancer data missed expectations

The Quick Take
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to Financial Times.


